Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04415645 · ClinicalTrials.gov registry record · Phase 1
Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects
A Phase 1 study, sponsored by Vivozon.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04415645 is a Phase 1 study that has completed, run by Vivozon. The registered enrollment target is 6 participants.
The verdict
NCT04415645, a Phase 1 study, has completed, sponsored by Vivozon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of \[14C\]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to measure total radioactivity and plasma drug concentrations.
Interventions
- DRUG [14C]-VVZ-149
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2020-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04415645
The ClinicalTrials.gov registry entry for NCT04415645 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivozon, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [14C]-VVZ-149 is the first listed.
NCT04415645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04415645 about?
NCT04415645 is a clinical study titled "Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects". This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of \[14C\]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to meas...
What is the current status of trial NCT04415645?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2020-02-24. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT04415645?
The interventions under investigation include: [14C]-VVZ-149 (DRUG).
Who is sponsoring clinical trial NCT04415645?
This trial is sponsored by Vivozon, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.